MATTHEW W FOEHR

CIK 1237556 · President and CEO · last filed 2026-04-07

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$45.77M

Companies

6

Total Filings

126

Lifetime Open-Market Net

-$24.19M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
OABIW President and CEO 4,420,492 $0.10 $441.6K $7.27M 33 2026-04-07
VKTX Director 135,186 $28.75 $3.89M -$286.7K 11 2026-01-05
LGND President and COO 162,187 $255.54 $41.45M -$31.25M 58 2022-11-03
Viking Therapeutics, Inc. (VKTXW) Delisted Director 46,250 $4.60 $212.7K -$79.9K 8 2021-03-25
Qualigen Therapeutics, Inc. (RTTR) Delisted Director 138,635 $133.1K 12 2020-04-23
Viking Therapeutics, Inc. (VKTX.W) Delisted Director 26,250 $24.8K 1 2016-04-13

Recent Filings · Page 13 of 13

126 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2012-12-05 LGND Buy (P) +370 $6.7K EDGAR
2012-07-03 LGND Other (J) +1,250 $12.7K EDGAR
2012-02-13 LGND Grant (A) +10,000 $0 EDGAR
2012-01-06 LGND Other (J) +1,250 $12.6K EDGAR
2011-04-20 LGND Grant (A) +25,000 $0 EDGAR
2007-01-03 Disp (D) −44,659 -$781.5K
Showing 121126 of 126
Page 13 of 13
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.